INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 300 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,101,082 | -29.3% | 129,699 | -8.8% | 0.01% | -25.0% |
| Q2 2023 | $5,797,774 | -5.3% | 142,172 | -13.5% | 0.01% | -11.1% |
| Q1 2023 | $6,123,573 | +63.1% | 164,303 | +52.7% | 0.01% | +50.0% |
| Q4 2022 | $3,754,652 | -20.0% | 107,614 | +28.3% | 0.01% | -25.0% |
| Q3 2022 | $4,693,000 | -2.2% | 83,860 | -8.3% | 0.01% | +14.3% |
| Q2 2022 | $4,797,000 | -25.9% | 91,491 | +1.9% | 0.01% | -22.2% |
| Q1 2022 | $6,478,000 | – | 89,747 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |